Intra‐ and interreader reproducibility of PI‐RADSv2: A multireader study

Background The Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI‐RADSv2. Purpose To evaluate both intra‐ and interrea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of magnetic resonance imaging Ročník 49; číslo 6; s. 1694 - 1703
Hlavní autoři: Smith, Clayton P., Harmon, Stephanie A., Barrett, Tristan, Bittencourt, Leonardo K., Law, Yan Mee, Shebel, Haytham, An, Julie Y., Czarniecki, Marcin, Mehralivand, Sherif, Coskun, Mehmet, Wood, Bradford J., Pinto, Peter A., Shih, Joanna H., Choyke, Peter L., Turkbey, Baris
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Wiley Subscription Services, Inc 01.06.2019
Témata:
ISSN:1053-1807, 1522-2586, 1522-2586
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background The Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI‐RADSv2. Purpose To evaluate both intra‐ and interreader reproducibility of PI‐RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI). Study Type Retrospective. Population/Subjects In all, 102 consecutive biopsy‐naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)‐guided biopsy. Field Strength/Sequences Prostate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI). Assessment Previously detected and biopsied lesions were scored by four readers from four different institutions using PI‐RADSv2. Readers scored lesions during two readout rounds with a 4‐week washout period. Statistical Tests Kappa (κ) statistics and specific agreement (Po) were calculated to quantify intra‐ and interreader reproducibility of PI‐RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC). Results Overall intrareader reproducibility was moderate to substantial (κ = 0.43–0.67, Po = 0.60–0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, Po = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence‐specific interreader agreement for all readers was similar to the overall PI‐RADSv2 score, with κ = 0.24, 0.24, and 0.23 and Po = 0.47, 0.44, and 0.54 in T2‐weighted, diffusion‐weighted imaging (DWI), and dynamic contrast‐enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively. Data Conclusion PI‐RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI. Level of Evidence: 2 Technical Efficacy: Stage 2
AbstractList The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI-RADSv2. To evaluate both intra- and interreader reproducibility of PI-RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI). Retrospective. In all, 102 consecutive biopsy-naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)-guided biopsy. Prostate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI). Previously detected and biopsied lesions were scored by four readers from four different institutions using PI-RADSv2. Readers scored lesions during two readout rounds with a 4-week washout period. Kappa (κ) statistics and specific agreement (P ) were calculated to quantify intra- and interreader reproducibility of PI-RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC). Overall intrareader reproducibility was moderate to substantial (κ = 0.43-0.67, P  = 0.60-0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, P  = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence-specific interreader agreement for all readers was similar to the overall PI-RADSv2 score, with κ = 0.24, 0.24, and 0.23 and P  = 0.47, 0.44, and 0.54 in T -weighted, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively. PI-RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI. 2 Technical Efficacy: Stage 2.
Background The Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI‐RADSv2. Purpose To evaluate both intra‐ and interreader reproducibility of PI‐RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI). Study Type Retrospective. Population/Subjects In all, 102 consecutive biopsy‐naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)‐guided biopsy. Field Strength/Sequences Prostate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI). Assessment Previously detected and biopsied lesions were scored by four readers from four different institutions using PI‐RADSv2. Readers scored lesions during two readout rounds with a 4‐week washout period. Statistical Tests Kappa (κ) statistics and specific agreement (Po) were calculated to quantify intra‐ and interreader reproducibility of PI‐RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC). Results Overall intrareader reproducibility was moderate to substantial (κ = 0.43–0.67, Po = 0.60–0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, Po = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence‐specific interreader agreement for all readers was similar to the overall PI‐RADSv2 score, with κ = 0.24, 0.24, and 0.23 and Po = 0.47, 0.44, and 0.54 in T2‐weighted, diffusion‐weighted imaging (DWI), and dynamic contrast‐enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively. Data Conclusion PI‐RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI. Level of Evidence: 2 Technical Efficacy: Stage 2
BackgroundThe Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI‐RADSv2.PurposeTo evaluate both intra‐ and interreader reproducibility of PI‐RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI).Study TypeRetrospective.Population/SubjectsIn all, 102 consecutive biopsy‐naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)‐guided biopsy.Field Strength/SequencesProstate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI).AssessmentPreviously detected and biopsied lesions were scored by four readers from four different institutions using PI‐RADSv2. Readers scored lesions during two readout rounds with a 4‐week washout period.Statistical TestsKappa (κ) statistics and specific agreement (Po) were calculated to quantify intra‐ and interreader reproducibility of PI‐RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC).ResultsOverall intrareader reproducibility was moderate to substantial (κ = 0.43–0.67, Po = 0.60–0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, Po = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence‐specific interreader agreement for all readers was similar to the overall PI‐RADSv2 score, with κ = 0.24, 0.24, and 0.23 and Po = 0.47, 0.44, and 0.54 in T2‐weighted, diffusion‐weighted imaging (DWI), and dynamic contrast‐enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively.Data ConclusionPI‐RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI.Level of Evidence: 2Technical Efficacy: Stage 2
The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI-RADSv2.BACKGROUNDThe Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI-RADSv2.To evaluate both intra- and interreader reproducibility of PI-RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI).PURPOSETo evaluate both intra- and interreader reproducibility of PI-RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI).Retrospective.STUDY TYPERetrospective.In all, 102 consecutive biopsy-naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)-guided biopsy.POPULATION/SUBJECTSIn all, 102 consecutive biopsy-naïve patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)-guided biopsy.Prostate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI).FIELD STRENGTH/SEQUENCESProstate mpMRI at 3T using endorectal with phased array surface coils (TW MRI, DW MRI with ADC maps and b2000 DW MRI, DCE MRI).Previously detected and biopsied lesions were scored by four readers from four different institutions using PI-RADSv2. Readers scored lesions during two readout rounds with a 4-week washout period.ASSESSMENTPreviously detected and biopsied lesions were scored by four readers from four different institutions using PI-RADSv2. Readers scored lesions during two readout rounds with a 4-week washout period.Kappa (κ) statistics and specific agreement (Po ) were calculated to quantify intra- and interreader reproducibility of PI-RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC).STATISTICAL TESTSKappa (κ) statistics and specific agreement (Po ) were calculated to quantify intra- and interreader reproducibility of PI-RADSv2 scoring. Lesion measurement agreement was calculated using the intraclass correlation coefficient (ICC).Overall intrareader reproducibility was moderate to substantial (κ = 0.43-0.67, Po  = 0.60-0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, Po  = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence-specific interreader agreement for all readers was similar to the overall PI-RADSv2 score, with κ = 0.24, 0.24, and 0.23 and Po  = 0.47, 0.44, and 0.54 in T2 -weighted, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively.RESULTSOverall intrareader reproducibility was moderate to substantial (κ = 0.43-0.67, Po  = 0.60-0.77), while overall interreader reproducibility was poor to moderate (κ = 0.24, Po  = 46). Readers with more experience showed greater interreader reproducibility than readers with intermediate experience in the whole prostate (P = 0.026) and peripheral zone (P = 0.002). Sequence-specific interreader agreement for all readers was similar to the overall PI-RADSv2 score, with κ = 0.24, 0.24, and 0.23 and Po  = 0.47, 0.44, and 0.54 in T2 -weighted, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE), respectively. Overall intrareader and interreader ICC for lesion measurement was 0.82 and 0.71, respectively.PI-RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI.DATA CONCLUSIONPI-RADSv2 provides moderate intrareader reproducibility, poor interreader reproducibility, and moderate interreader lesion measurement reproducibility. These findings suggest a need for more standardized reader training in prostate MRI.2 Technical Efficacy: Stage 2.LEVEL OF EVIDENCE2 Technical Efficacy: Stage 2.
Author Shih, Joanna H.
Smith, Clayton P.
Mehralivand, Sherif
Law, Yan Mee
Czarniecki, Marcin
Bittencourt, Leonardo K.
Coskun, Mehmet
Harmon, Stephanie A.
Shebel, Haytham
An, Julie Y.
Choyke, Peter L.
Barrett, Tristan
Turkbey, Baris
Pinto, Peter A.
Wood, Bradford J.
Author_xml – sequence: 1
  givenname: Clayton P.
  orcidid: 0000-0002-8509-6237
  surname: Smith
  fullname: Smith, Clayton P.
  organization: Georgetown University School of Medicine
– sequence: 2
  givenname: Stephanie A.
  surname: Harmon
  fullname: Harmon, Stephanie A.
  organization: Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute
– sequence: 3
  givenname: Tristan
  surname: Barrett
  fullname: Barrett, Tristan
  organization: Addenbrooke's Hospital and the University of Cambridge
– sequence: 4
  givenname: Leonardo K.
  orcidid: 0000-0001-9175-9626
  surname: Bittencourt
  fullname: Bittencourt, Leonardo K.
  organization: CDPI Clinics, DASA
– sequence: 5
  givenname: Yan Mee
  surname: Law
  fullname: Law, Yan Mee
  organization: Singapore General Hospital
– sequence: 6
  givenname: Haytham
  surname: Shebel
  fullname: Shebel, Haytham
  organization: Mansoura University
– sequence: 7
  givenname: Julie Y.
  surname: An
  fullname: An, Julie Y.
  organization: Northeast Ohio Medical University
– sequence: 8
  givenname: Marcin
  orcidid: 0000-0002-6786-9910
  surname: Czarniecki
  fullname: Czarniecki, Marcin
  organization: Molecular Imaging Program, National Cancer Institute, NIH
– sequence: 9
  givenname: Sherif
  surname: Mehralivand
  fullname: Mehralivand, Sherif
  organization: University Medical Center
– sequence: 10
  givenname: Mehmet
  surname: Coskun
  fullname: Coskun, Mehmet
  organization: University of Health Sciences
– sequence: 11
  givenname: Bradford J.
  surname: Wood
  fullname: Wood, Bradford J.
  organization: National Cancer Institute, NIH
– sequence: 12
  givenname: Peter A.
  surname: Pinto
  fullname: Pinto, Peter A.
  organization: National Cancer Institute, NIH
– sequence: 13
  givenname: Joanna H.
  surname: Shih
  fullname: Shih, Joanna H.
  organization: Biometric Research Program, National Cancer Institute, NIH
– sequence: 14
  givenname: Peter L.
  surname: Choyke
  fullname: Choyke, Peter L.
  organization: Molecular Imaging Program, National Cancer Institute, NIH
– sequence: 15
  givenname: Baris
  orcidid: 0000-0003-0853-6494
  surname: Turkbey
  fullname: Turkbey, Baris
  email: turkbeyi@mail.nih.gov
  organization: Molecular Imaging Program, National Cancer Institute, NIH
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30575184$$D View this record in MEDLINE/PubMed
BookMark eNp90ctKAzEUBuAgFXvRjQ8gA25EmHqSTObirtRbpaJUXYfMTAIpc6nJjNKdj-Az-iSmtroo4iqH8J3D4fx91KnqSiJ0iGGIAcjZvDR6SELG2A7qYUaIT1gcdlwNjPo4hqiL-tbOASBJAraHuhRYxHAc9NB0UjVGfL5_eKLKPV010hgpcmk8IxemzttMp7rQzdKrlfcwcXA2unh8JefeyCvbotEbbZs2X-6jXSUKKw827wA9X10-jW_86f31ZDya-lnAEuarKFOEhoSmkcREJgSoCqMMQAUQp2kggGJMMWUqiJSkYS5gVWZxLhL3regAnaznug1fWmkbXmqbyaIQlaxbywlmSRKTGMeOHm_Red2aym3HCSHuDBGhiVNHG9Wmpcz5wuhSmCX_uZMDp2uQmdpaI9UvwcBXIfBVCPw7BIdhC2e6EY2uV6fWxd8teN3ypgu5_Gc4v72bTdY9X-UrmNg
CitedBy_id crossref_primary_10_1002_jmri_26943
crossref_primary_10_1002_jmri_28609
crossref_primary_10_1148_radiol_240041
crossref_primary_10_1007_s00345_021_03891_3
crossref_primary_10_1002_jmri_29659
crossref_primary_10_1002_jmri_26945
crossref_primary_10_1186_s12929_021_00750_6
crossref_primary_10_1002_jmri_27191
crossref_primary_10_1186_s13244_023_01421_w
crossref_primary_10_1016_j_ejrad_2024_111470
crossref_primary_10_1186_s13244_023_01391_z
crossref_primary_10_1148_radiol_230750
crossref_primary_10_1259_bjr_20211372
crossref_primary_10_3390_diagnostics13040615
crossref_primary_10_3389_fonc_2022_961985
crossref_primary_10_1259_bjr_20210563
crossref_primary_10_1016_j_ejrad_2021_109894
crossref_primary_10_3390_cancers16172951
crossref_primary_10_1016_j_urolonc_2020_01_017
crossref_primary_10_3390_diagnostics11060959
crossref_primary_10_1097_RLI_0000000000001218
crossref_primary_10_1016_j_ucl_2023_08_001
crossref_primary_10_1007_s00330_020_07086_z
crossref_primary_10_1186_s13244_023_01574_8
crossref_primary_10_1016_j_acra_2025_03_039
crossref_primary_10_1007_s00330_023_09433_2
crossref_primary_10_1016_j_compbiomed_2024_107999
crossref_primary_10_1038_s41391_025_00990_9
crossref_primary_10_1111_bju_16041
crossref_primary_10_1007_s00261_019_02114_z
crossref_primary_10_3390_cancers13081978
crossref_primary_10_1016_j_euros_2022_09_024
crossref_primary_10_1007_s10278_022_00662_3
crossref_primary_10_1111_bju_14957
crossref_primary_10_3389_fonc_2020_603384
crossref_primary_10_1002_mrm_29565
crossref_primary_10_1111_bju_16452
crossref_primary_10_1186_s41747_021_00252_y
crossref_primary_10_1007_s10334_022_01013_7
crossref_primary_10_1016_j_compeleceng_2022_108275
crossref_primary_10_1007_s00330_019_06436_w
crossref_primary_10_1002_jmri_29660
crossref_primary_10_3390_cancers15235659
crossref_primary_10_1007_s00330_019_06654_2
crossref_primary_10_1148_radiol_241009
crossref_primary_10_1097_MOU_0000000000000822
crossref_primary_10_17816_DD637445
crossref_primary_10_1007_s00259_024_06916_2
crossref_primary_10_1007_s00330_021_08320_y
crossref_primary_10_1007_s00330_021_07693_4
crossref_primary_10_1186_s13244_023_01386_w
crossref_primary_10_1007_s00345_024_04995_2
crossref_primary_10_1016_j_acra_2022_06_024
crossref_primary_10_62347_CSIJ8326
crossref_primary_10_3389_fonc_2022_994296
crossref_primary_10_3389_fonc_2023_1189370
crossref_primary_10_1038_s41585_022_00648_4
crossref_primary_10_1016_j_cmpb_2020_105316
crossref_primary_10_1002_jmri_26975
crossref_primary_10_1007_s00330_020_07030_1
crossref_primary_10_1007_s00330_024_11287_1
crossref_primary_10_1016_j_euf_2019_04_010
crossref_primary_10_1016_j_euo_2020_02_005
crossref_primary_10_1097_JU9_0000000000000310
crossref_primary_10_1148_radiol_2020201473
crossref_primary_10_1007_s11934_019_0923_3
crossref_primary_10_33719_nju1557986
crossref_primary_10_3389_fonc_2021_610785
crossref_primary_10_1038_s41598_023_31869_1
crossref_primary_10_1007_s00330_019_06557_2
crossref_primary_10_3390_diagnostics12020289
crossref_primary_10_1016_j_ijrobp_2023_07_029
crossref_primary_10_1148_radiol_232635
crossref_primary_10_1002_jmri_26928
crossref_primary_10_1002_pros_24608
crossref_primary_10_1016_j_rcl_2023_06_010
crossref_primary_10_1038_s41584_021_00719_7
crossref_primary_10_1002_jmri_26803
crossref_primary_10_1002_jmri_28428
crossref_primary_10_1038_s41416_022_02137_2
crossref_primary_10_1016_j_rcl_2023_06_006
crossref_primary_10_1038_s41391_023_00782_z
crossref_primary_10_1109_TMI_2020_3043641
crossref_primary_10_3390_app13179871
crossref_primary_10_1007_s00330_019_06092_0
crossref_primary_10_1016_j_media_2021_102155
crossref_primary_10_1002_jmri_27204
crossref_primary_10_1007_s00330_025_11865_x
crossref_primary_10_1002_jmri_27841
crossref_primary_10_1001_jamanetworkopen_2025_15672
crossref_primary_10_1007_s10334_022_01011_9
crossref_primary_10_1177_08465371221135782
crossref_primary_10_3390_life12101490
crossref_primary_10_1016_j_yacr_2021_04_004
crossref_primary_10_1186_s13244_023_01439_0
crossref_primary_10_1148_radiol_2019190938
crossref_primary_10_1148_radiol_2021204112
crossref_primary_10_1007_s11255_021_03071_7
Cites_doi 10.1148/radiol.16151133
10.1177/0962280214534651
10.1111/bju.12871
10.1097/00000478-198812000-00001
10.1148/radiol.2015142818
10.1148/radiol.2017152877
10.1007/s00330-013-2922-y
10.1259/bjr/21256379
10.2214/AJR.15.15765
10.2214/AJR.12.10178
10.1148/radiol.2016152542
10.1056/NEJMoa1801993
10.6004/jnccn.2016.0060
10.1007/s00330-011-2377-y
10.1016/j.eururo.2010.12.009
10.1016/0022-3956(82)90039-5
10.1016/j.juro.2015.11.055
10.1016/j.clinimag.2014.08.008
10.1055/s-0032-1312876
10.1002/jmri.25372
10.1016/j.juro.2015.02.080
10.1016/j.euf.2017.11.010
10.1016/j.juro.2015.05.078
10.1002/jmri.25948
10.1016/j.juro.2011.05.078
10.1016/j.eururo.2014.09.018
10.2214/AJR.15.15049
10.1016/j.eururo.2015.08.052
10.2214/AJR.12.10173
10.2214/AJR.16.16561
ContentType Journal Article
Copyright 2018 International Society for Magnetic Resonance in Medicine
2018 International Society for Magnetic Resonance in Medicine.
2019 International Society for Magnetic Resonance in Medicine
Copyright_xml – notice: 2018 International Society for Magnetic Resonance in Medicine
– notice: 2018 International Society for Magnetic Resonance in Medicine.
– notice: 2019 International Society for Magnetic Resonance in Medicine
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
DOI 10.1002/jmri.26555
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 1703
ExternalDocumentID 30575184
10_1002_jmri_26555
JMRI26555
Genre article
Multicenter Study
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: National Institutes of Health
  funderid: HHSN261200800001E
– fundername: National Cancer Institute
– fundername: Intramural NIH HHS
  grantid: Z99 CA999999
– fundername: Intramural NIH HHS
  grantid: ZIA CL040015
– fundername: Cancer Research UK
  grantid: 16465
– fundername: CCR NIH HHS
  grantid: HHSN261200800001C
– fundername: NCI NIH HHS
  grantid: HHSN261200800001E
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c4595-f7cf23623b7e12e9203f67c00f408bb4a03113135f47fe36da05f47c8da9313f3
IEDL.DBID DRFUL
ISICitedReferencesCount 113
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000467588500018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1053-1807
1522-2586
IngestDate Fri Jul 11 08:50:35 EDT 2025
Sat Nov 29 15:01:09 EST 2025
Mon Jul 21 05:35:37 EDT 2025
Sat Nov 29 06:08:26 EST 2025
Tue Nov 18 21:32:37 EST 2025
Wed Jan 22 16:20:29 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords prostate cancer
reader reproducibility
MRI
PI-RADS
Language English
License 2018 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4595-f7cf23623b7e12e9203f67c00f408bb4a03113135f47fe36da05f47c8da9313f3
Notes The first two authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8509-6237
0000-0002-6786-9910
0000-0003-0853-6494
0000-0001-9175-9626
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6504619
PMID 30575184
PQID 2220577239
PQPubID 1006400
PageCount 15
ParticipantIDs proquest_miscellaneous_2159982818
proquest_journals_2220577239
pubmed_primary_30575184
crossref_primary_10_1002_jmri_26555
crossref_citationtrail_10_1002_jmri_26555
wiley_primary_10_1002_jmri_26555_JMRI26555
PublicationCentury 2000
PublicationDate June 2019
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: June 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2012; 184
2018; 286
2015; 39
1982; 17
2016; 207
2013; 23
2016; 206
2017; 45
1988; 12
2013; 201
2013; 185
2011; 59
2016; 280
2016; 14
2015; 67
2015; 194
2015; 115
2015; 277
2018
2017
2013
2012; 22
2016; 69
2016; 25
2012; 85
2016; 195
2011; 186
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
Mehralivand S (e_1_2_7_7_1) 2018
Röthke M (e_1_2_7_3_1) 2013; 185
e_1_2_7_8_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
D'Orsi CJ (e_1_2_7_9_1) 2013
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – year: 2018
  article-title: A magnetic resonance imaging‐based prediction model for prostate biopsy risk stratification
  publication-title: JAMA Oncol
– volume: 22
  start-page: 746
  year: 2012
  end-page: 757
  article-title: ESUR prostate MR guidelines 2012
  publication-title: Eur Radiol
– volume: 25
  start-page: 2939
  year: 2016
  end-page: 2958
  article-title: Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting
  publication-title: Stat Methods Med Res
– volume: 195
  start-page: 1421
  year: 2016
  end-page: 1427
  article-title: Serial magnetic resonance imaging in active surveillance of prostate cancer: incremental value
  publication-title: J Urol
– volume: 184
  start-page: 925
  year: 2012
  end-page: 929
  article-title: Interreader agreement of multi‐parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system
  publication-title: Rofo
– volume: 206
  start-page: 1119
  year: 2016
  end-page: 1123
  article-title: Assessment of interradiologist agreement regarding mammographic breast density classification using the Fifth Edition of the BI‐RADS Atlas
  publication-title: AJR Am J Roentgenol
– volume: 194
  start-page: 364
  year: 2015
  end-page: 370
  article-title: Image guided focal therapy for magnetic resonance imaging visible prostate cancer: defining a 3‐dimensional treatment margin based on magnetic resonance imaging histology co‐registration analysis
  publication-title: J Urol
– volume: 67
  start-page: 771
  year: 2015
  end-page: 777
  article-title: Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting
  publication-title: Eur Urol
– volume: 115
  start-page: 772
  year: 2015
  end-page: 779
  article-title: Comparison of magnetic resonance imaging and ultrasound (MRI‐US) fusion‐guided prostate biopsies obtained from axial and sagittal approaches
  publication-title: BJU Int
– volume: 201
  start-page: W612
  year: 2013
  end-page: 18
  article-title: Comparison of interreader reproducibility of the prostate imaging reporting and data system and Likert scales for evaluation of multiparametric prostate MRI
  publication-title: AJR Am J Roentgenol
– volume: 39
  start-page: 264
  year: 2015
  end-page: 269
  article-title: Association between changes in suspicious prostate lesions on serial MRI examinations and follow‐up biopsy results
  publication-title: Clin Imaging
– volume: 85
  start-page: 1465
  year: 2012
  end-page: 1470
  article-title: Inter‐ and intraradiologist variability in the BI‐RADS assessment and breast density categories for screening mammograms
  publication-title: Br J Radiol
– volume: 45
  start-page: 579
  year: 2017
  end-page: 585
  article-title: Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study
  publication-title: J Magn Reson Imaging
– year: 2018
  article-title: All over the map: An interobserver agreement study of tumor location based on the PI‐RADSv2 sector map
  publication-title: J Magn Reson Imaging
– volume: 280
  start-page: 793
  year: 2016
  end-page: 804
  article-title: Interobserver reproducibility of the PI‐RADS Version 2 Lexicon: A multicenter study of six experienced prostate radiologists
  publication-title: Radiology
– volume: 194
  start-page: 1234
  year: 2015
  end-page: 1240
  article-title: Natural history of pathologically benign cancer suspicious regions on multiparametric magnetic resonance imaging following targeted biopsy
  publication-title: J Urol
– volume: 23
  start-page: 3185
  year: 2013
  end-page: 3190
  article-title: Interreader agreement of the ESUR score for prostate MRI using in‐bore MRI‐guided biopsies as the reference standard
  publication-title: Eur Radiol
– volume: 59
  start-page: 477
  year: 2011
  end-page: 494
  article-title: Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting
  publication-title: Eur Urol
– volume: 186
  start-page: 1281
  year: 2011
  end-page: 1285
  article-title: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging
  publication-title: J Urol
– volume: 280
  start-page: 108
  year: 2016
  end-page: 116
  article-title: Prostate cancer: PI‐RADS Version 2 helps preoperatively predict clinically significant cancers
  publication-title: Radiology
– volume: 12
  start-page: 897
  year: 1988
  end-page: 906
  article-title: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread
  publication-title: Am J Surg Pathol
– volume: 201
  start-page: 1229
  year: 2013
  end-page: 1238
  article-title: The expanding role of MRI in prostate cancer
  publication-title: AJR Am J Roentgenol
– volume: 14
  start-page: 509
  year: 2016
  end-page: 519
  article-title: NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2. 2016
  publication-title: J Natl Compr Cancer Netw
– volume: 185
  start-page: 253
  year: 2013
  end-page: 261
  article-title: [PI‐RADS classification: structured reporting for MRI of the prostate]
  publication-title: Rofo
– year: 2017
  article-title: Prostate magnetic resonance imaging interpretation varies substantially across radiologists
  publication-title: 2 Eur Urol Focus
– volume: 206
  start-page: 1179
  year: 2016
  end-page: 1183
  article-title: Prostate Imaging Reporting and Data System (PI‐RADS), Version 2: A critical look
  publication-title: AJR Am J Roentgenol
– volume: 286
  start-page: 186
  year: 2018
  end-page: 195
  article-title: What are we missing?. False‐negative cancers at multiparametric MR imaging of the prostate
  publication-title: Radiology
– volume: 69
  start-page: 16
  year: 2016
  end-page: 40
  article-title: PI‐RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
  publication-title: Eur Urol
– year: 2018
  article-title: MRI‐targeted or standard biopsy for prostate‐cancer diagnosis
  publication-title: N Engl J Med
– volume: 207
  start-page: 1366
  year: 2016
  end-page: 1371
  article-title: Effects of changes in BI‐RADS Density Assessment Guidelines (Fourth Versus Fifth Edition) on breast density assessment: intra‐ and interreader agreements and density distribution
  publication-title: AJR Am J Roentgenol
– volume: 17
  start-page: 335
  year: 1982
  end-page: 342
  article-title: A design‐independent method for measuring the reliability of psychiatric diagnosis
  publication-title: J Psychiatr Res
– volume: 277
  start-page: 741
  year: 2015
  end-page: 750
  article-title: Prostate cancer: interobserver agreement and accuracy with the Revised Prostate Imaging Reporting and Data System at multiparametric MR imaging
  publication-title: Radiology
– year: 2013
– ident: e_1_2_7_26_1
  doi: 10.1148/radiol.16151133
– volume-title: ACR BI‐RADS Atlas: Breast Imaging Reporting and Data System
  year: 2013
  ident: e_1_2_7_9_1
– ident: e_1_2_7_20_1
  doi: 10.1177/0962280214534651
– ident: e_1_2_7_18_1
  doi: 10.1111/bju.12871
– ident: e_1_2_7_27_1
  doi: 10.1097/00000478-198812000-00001
– ident: e_1_2_7_14_1
  doi: 10.1148/radiol.2015142818
– ident: e_1_2_7_33_1
  doi: 10.1148/radiol.2017152877
– ident: e_1_2_7_11_1
  doi: 10.1007/s00330-013-2922-y
– ident: e_1_2_7_21_1
  doi: 10.1259/bjr/21256379
– ident: e_1_2_7_25_1
  doi: 10.2214/AJR.15.15765
– ident: e_1_2_7_2_1
  doi: 10.2214/AJR.12.10178
– volume: 185
  start-page: 253
  year: 2013
  ident: e_1_2_7_3_1
  article-title: [PI‐RADS classification: structured reporting for MRI of the prostate]
  publication-title: Rofo
– ident: e_1_2_7_15_1
  doi: 10.1148/radiol.2016152542
– ident: e_1_2_7_6_1
  doi: 10.1056/NEJMoa1801993
– ident: e_1_2_7_5_1
  doi: 10.6004/jnccn.2016.0060
– ident: e_1_2_7_8_1
  doi: 10.1007/s00330-011-2377-y
– ident: e_1_2_7_13_1
  doi: 10.1016/j.eururo.2010.12.009
– ident: e_1_2_7_19_1
  doi: 10.1016/0022-3956(82)90039-5
– ident: e_1_2_7_30_1
  doi: 10.1016/j.juro.2015.11.055
– ident: e_1_2_7_29_1
  doi: 10.1016/j.clinimag.2014.08.008
– ident: e_1_2_7_12_1
  doi: 10.1055/s-0032-1312876
– ident: e_1_2_7_24_1
  doi: 10.1002/jmri.25372
– ident: e_1_2_7_31_1
  doi: 10.1016/j.juro.2015.02.080
– year: 2018
  ident: e_1_2_7_7_1
  article-title: A magnetic resonance imaging‐based prediction model for prostate biopsy risk stratification
  publication-title: JAMA Oncol
– ident: e_1_2_7_16_1
  doi: 10.1016/j.euf.2017.11.010
– ident: e_1_2_7_28_1
  doi: 10.1016/j.juro.2015.05.078
– ident: e_1_2_7_34_1
  doi: 10.1002/jmri.25948
– ident: e_1_2_7_17_1
  doi: 10.1016/j.juro.2011.05.078
– ident: e_1_2_7_32_1
  doi: 10.1016/j.eururo.2014.09.018
– ident: e_1_2_7_23_1
  doi: 10.2214/AJR.15.15049
– ident: e_1_2_7_4_1
  doi: 10.1016/j.eururo.2015.08.052
– ident: e_1_2_7_10_1
  doi: 10.2214/AJR.12.10173
– ident: e_1_2_7_22_1
  doi: 10.2214/AJR.16.16561
SSID ssj0009945
Score 2.5813737
Snippet Background The Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied,...
The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has...
BackgroundThe Prostate Imaging Reporting and Data System version 2 (PI‐RADSv2) has been in use since 2015; while interreader reproducibility has been studied,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1694
SubjectTerms Adult
Aged
Aged, 80 and over
Algorithms
Biopsy
Biopsy - methods
Contrast Media
Correlation coefficient
Correlation coefficients
Diffusion Magnetic Resonance Imaging
Field strength
Humans
Image-Guided Biopsy
Lesions
Magnetic Resonance Imaging
Male
Mathematical analysis
Medical imaging
Middle Aged
MRI
Multiparametric Magnetic Resonance Imaging
NMR
Nuclear magnetic resonance
Observer Variation
PI‐RADS
Population (statistical)
Population studies
Prostate
Prostate - pathology
Prostate cancer
Prostate-Specific Antigen - analysis
Prostatic Neoplasms - diagnostic imaging
reader reproducibility
Readers
Reference Standards
Reproducibility
Reproducibility of Results
Retrospective Studies
Statistical analysis
Statistical tests
Ultrasonography
Ultrasound
Title Intra‐ and interreader reproducibility of PI‐RADSv2: A multireader study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.26555
https://www.ncbi.nlm.nih.gov/pubmed/30575184
https://www.proquest.com/docview/2220577239
https://www.proquest.com/docview/2159982818
Volume 49
WOSCitedRecordID wos000467588500018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1522-2586
  dateEnd: 20201207
  omitProxy: false
  ssIdentifier: ssj0009945
  issn: 1053-1807
  databaseCode: WIN
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1522-2586
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009945
  issn: 1053-1807
  databaseCode: DRFUL
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fT9swED9BmSZe2GADAgx5Yi-bFHD9p7GnvVRjFZ2gQt3Q-ha5ji2BIEUprcQbH4HPyCfBdtJUiAlp2puTXOTo_uTOvvPvAD45r2acVxUxzgiNGct4rDTHsVSMS0sNJ1qFZhNJrycGA3m6AN9mZ2FKfIh6w81bRvhfewNXw_HBHDT04qo43yctzvkiLBGnuLwBS4f9ztnxHHRXhibFLoSgcVPgpIYnJQfzt586pGdR5tOgNXidzpv_-963sFJFm6hdqscqLJh8DV6fVPn0d3Dc9Xu7D3f3SOUZ8tARRRFqm5EHu_RYsGXx7C0aWXTadYT99uGvKfmK2iiUIlbUAaT2PZx1fvz-fhRX_RVi7QTBY5toS5wDo8PENImRBFPbSjTGlmExHDLlDL5Jm5RbllhDW5nCfqhFpqS7bek6NPJRbjYBScINJZJp6RdomkqtBGVcZFwzY1gSwecZk1NdgY_7HhiXaQmbTFLPnjSwJ4K9mva6hNz4K9XOTFZpZXbjlPhjw269QGUEH-vHzmB8FkTlZjRxNC6Ak8KDYEWwUcq4nobikIZiEXwJonxh_vTnSb8bRlv_QrwNyy7kkmWx2Q40boqJ-QCv9PTmfFzswmIyELuVGrurP93eI_5b9NU
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RQG0vPFrahkcxgkuRUhw_NjG3FQ9t2t0IUSq4RV7HlqjabBV2kXrrT-A38kuwnWxWiKpS1ZuVjOXI48l89oy_AdizXk1br5qEuCA0ZKzgoVQch0IyLgzVnCjpi03EWZZcXYmzJjfH3YWp-SHaAzdnGf5_7QzcHUgfzFhDv_2orj-SDuf8GSwwizRc5YbLNJtx7gpfo9giCBpGCY5bdlJyMOv72B89AZmPMat3OqfL__m5K7DUoE3UrZfHKszp8hU8HzTx9NfQT93Z7v3vOyTLAjnqiKryuc3IkV06Ltg6efYXGhl0llrB8-7xl1tyiLrIpyI20p6kdg2-np5cHPXCpr5CqKwieGhiZYh1YHQY64hoQTA1nVhhbBhOhkMmrcFHNKLcsNho2ikkdk2VFFLYx4a-gflyVOp3gAThmhLBlHAbNEWFkgllPCm4YlqzOIAP01nOVUM-7mpgfM9r2mSSu-nJ_fQEsNvK_qwpN_4otTlVVt6Y3U1O3LVhu1-gIoCd9rU1GBcFkaUeTayMBXAicSRYAbytldwOQ7EPQ7EA9r0u_zJ-_mlwnvrW-r8Ib8OL3sWgn_fT7PMGvLTwS9SJZ5swP64megsW1e34-qZ679fyAzSJ9aA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFD506Sh96dpdOm-9qGwvG3iVdYmtvYWmoW6TELIG-mYUWYKMzQnuBfq2n7DfuF8ySXYdSstg9E3YR8gc6fh80jn6DsBH69W09apJiHNCQ8ZyHkrFcSgk48JQzYmSvthEPBwmFxdiVOfmuLswFT9Ec-DmLMP_r52B60VuDpesod9_lrMvpM05fwarzFWRacFqd9yb9Jesu8JXKbYYgoZRguOGn5QcLnvf90gPYOZ91OrdTu_FEz94EzZqvIk61QLZghVdvIS1QR1RfwX91J3u_vn1G8kiR448oix9djNydJeODbZKn71Fc4NGqRUcd7rfbshX1EE-GbGW9jS1r2HSOz4_OgnrCguhsgrjoYmVIdaF0WmsI6IFwdS0Y4WxYTiZTpm0Jh_RiHLDYqNpO5fYNVWSS2EfG_oGWsW80G8BCcI1JYIp4bZoigolE8p4knPFtGZxAJ_utJypmn7cVcH4kVXEySRz6sm8egL40MguKtKNR6V27iYrqw3vMiPu4rDdMVARwEHz2pqMi4PIQs-vrYyFcCJxNFgBbFeT3AxDsQ9EsQA--7n8x_jZ6WCc-ta7_xHeh7VRt5f10-HZe1i3-EtUmWc70Loqr_UuPFc3V7PLcq9ezH8BuEr2SQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intra-+and+interreader+reproducibility+of+PI-RADSv2%3A+A+multireader+study&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Smith%2C+Clayton+P&rft.au=Harmon%2C+Stephanie+A&rft.au=Barrett%2C+Tristan&rft.au=Bittencourt%2C+Leonardo+K&rft.date=2019-06-01&rft.eissn=1522-2586&rft.volume=49&rft.issue=6&rft.spage=1694&rft_id=info:doi/10.1002%2Fjmri.26555&rft_id=info%3Apmid%2F30575184&rft.externalDocID=30575184
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon